1. Home
  2. IOBT vs HEQ Comparison

IOBT vs HEQ Comparison

Compare IOBT & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOBT
  • HEQ
  • Stock Information
  • Founded
  • IOBT 2014
  • HEQ 2011
  • Country
  • IOBT Denmark
  • HEQ United States
  • Employees
  • IOBT N/A
  • HEQ N/A
  • Industry
  • IOBT Biotechnology: Pharmaceutical Preparations
  • HEQ Investment Managers
  • Sector
  • IOBT Health Care
  • HEQ Finance
  • Exchange
  • IOBT Nasdaq
  • HEQ Nasdaq
  • Market Cap
  • IOBT 114.6M
  • HEQ 130.4M
  • IPO Year
  • IOBT 2021
  • HEQ N/A
  • Fundamental
  • Price
  • IOBT $1.62
  • HEQ $10.53
  • Analyst Decision
  • IOBT Strong Buy
  • HEQ
  • Analyst Count
  • IOBT 2
  • HEQ 0
  • Target Price
  • IOBT $8.00
  • HEQ N/A
  • AVG Volume (30 Days)
  • IOBT 1.1M
  • HEQ 43.1K
  • Earning Date
  • IOBT 11-11-2025
  • HEQ 01-01-0001
  • Dividend Yield
  • IOBT N/A
  • HEQ 9.78%
  • EPS Growth
  • IOBT N/A
  • HEQ N/A
  • EPS
  • IOBT N/A
  • HEQ N/A
  • Revenue
  • IOBT N/A
  • HEQ N/A
  • Revenue This Year
  • IOBT N/A
  • HEQ N/A
  • Revenue Next Year
  • IOBT N/A
  • HEQ N/A
  • P/E Ratio
  • IOBT N/A
  • HEQ N/A
  • Revenue Growth
  • IOBT N/A
  • HEQ N/A
  • 52 Week Low
  • IOBT $0.66
  • HEQ $9.08
  • 52 Week High
  • IOBT $2.79
  • HEQ $11.84
  • Technical
  • Relative Strength Index (RSI)
  • IOBT 44.35
  • HEQ 35.61
  • Support Level
  • IOBT $1.71
  • HEQ $10.57
  • Resistance Level
  • IOBT $2.08
  • HEQ $10.74
  • Average True Range (ATR)
  • IOBT 0.15
  • HEQ 0.09
  • MACD
  • IOBT -0.01
  • HEQ -0.04
  • Stochastic Oscillator
  • IOBT 16.36
  • HEQ 1.43

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: